Related Experiment Video
Updated: Jan 19, 2026
03:40
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
1.3K
[INVESTIGATION OF SUBCUTANEOUS IMMUNOTHERAPY FOR ALLERGIC RHINITIS IN OUR HOSPITAL FOR THE PAST 17 YEARS]
Hiroko Ishizu1,2, Satomi Mori1, Shuntarou Tsumagari1
1Department of Allergy, Kanagawa Children's Medical Center.
Arerugi = [Allergy]
|September 20, 2019
Summary
Subcutaneous immunotherapy (SCIT) is effective for childhood allergic rhinitis, offering long-term symptom relief and high patient satisfaction. This treatment option provides lasting benefits even after cessation.
Area of Science:
- Allergy and Immunology
- Pediatric Medicine
- Otolaryngology
Background:
- Subcutaneous immunotherapy (SCIT) use has been limited in the region.
- A 17-year investigation into SCIT for allergic rhinitis was conducted.
- SCIT is a potential treatment for allergic rhinitis.
Purpose of the Study:
- To evaluate the efficacy and safety of SCIT for allergic rhinitis in children.
- To assess long-term effects and patient satisfaction with SCIT.
- To compare SCIT with other immunotherapy options.
Main Methods:
- 188 pediatric patients undergoing rush SCIT under hospitalization were analyzed.
- Data collected included patient demographics, laboratory findings, and adverse reactions.
- Questionnaires assessed treatment outcomes and satisfaction levels.
Main Results:
- The median age of patients starting SCIT was 10 years and 4 months.
- Cedar pollen and mites were the most common allergens; 85% received multi-allergen treatment.
- Medication and symptom scores significantly decreased post-SCIT, with sustained effects for over 3 years.
- Adverse reactions were infrequent (2% during rapid phase, 0.2% during maintenance) and transient.
Conclusions:
- SCIT is a safe and effective treatment for childhood allergic rhinitis.
- SCIT provides long-lasting symptom control and high patient satisfaction.
- SCIT offers advantages over sublingual immunotherapy and should be considered for pediatric allergic rhinitis treatment.
